Home - Products - Others - Other Targets - 6-(4-Methoxyphenyl)-3-pyridazinamine

6-(4-Methoxyphenyl)-3-pyridazinamine

CAS No. 4776-87-8

6-(4-Methoxyphenyl)-3-pyridazinamine( —— )

Catalog No. M21069 CAS No. 4776-87-8

6-(4-Methoxyphenyl)-3-pyridazinamine is a GABAA receptor antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
10MG 30 In Stock
25MG 65 In Stock
50MG 103 In Stock
100MG 161 In Stock
200MG 230 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    6-(4-Methoxyphenyl)-3-pyridazinamine
  • Note
    Research use only, not for human use.
  • Brief Description
    6-(4-Methoxyphenyl)-3-pyridazinamine is a GABAA receptor antagonist.
  • Description
    6-(4-Methoxyphenyl)-3-pyridazinamine is a GABAA receptor antagonist.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    GABAA
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    4776-87-8
  • Formula Weight
    201.22
  • Molecular Formula
    C11H11N3O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:15mg/ml(74.5mM)
  • SMILES
    COc1ccc(-c2ccc(N)nn2)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Wermuth C G Bourguignon J J Schlewer G et al. ChemInform Abstract: Synthesis and Structure-Activity Relationships of a Series of Aminopyridazine Derivatives of γ-Aminobutyric Acid Acting as Selective GABA-A Antagonists.[J]. ChemInform 1987 18(28).
molnova catalog
related products
  • Histone H3 (116–136)...

    Histone H3 (116–136), N15–39

  • SAR7334 hydrochlorid...

    SAR7334 hydrochloride, a potent and specific inhibitor of TRPC6 (IC50 of 7.9 nM), effectively targets and inhibits the TRPC6 channel.

  • Scopine

    Scopine, the metabolite of anisodine, is an α1-adrenergic receptor agonist used in the therapy of acute circulatory shock.